Independent pricing research. We may earn a commission from provider links — how we make money.

What menopause HRT costs without insurance: every real path, cheapest first

Menopause telehealth ads quote a single friendly number. The market actually runs on four different pricing models — and which one is cheapest for you depends almost entirely on one question: does anything bill your insurance? Here's every legitimate path, with the honest math.

Step 0: check insurance anyway

Even if you assume you're not covered, spend ten minutes confirming — because the insured path isn't 10% cheaper, it's usually several times cheaper. Generic estradiol tablets, patches, and micronized progesterone are on most commercial formularies. And unlike GLP-1s, the clinician visit can be insured too: Midi Health bills most major PPO plans (Blue Cross Blue Shield, UnitedHealthcare, Cigna, Aetna and more) like a normal specialist visit, in all 50 states. Copay + covered generic is the number every cash subscription below has to beat, and most can't. Employer route worth one email: some health plans include Gennev or Maven Clinic menopause care at no cost. Nobody in this paragraph pays us anything — it's first because it's cheapest.

What actually drives the price

Every menopause telehealth bill is some combination of four parts. Providers differ mainly in which parts they charge for and which they hide:

The pharmacy-generic path: often the true floor

The quiet fact of this market: estradiol and micronized progesterone are old, generic, FDA-approved prescription drugs. Any clinician — your OB-GYN, your PCP, or any telehealth service — can prescribe them to a regular pharmacy, where cash prices with a discount card are frequently lower than any telehealth platform's medication price, and insured prices lower still. Exact generic prices vary too much by pharmacy, dose, and form for us to print one honest number; check a discount-card price for your specific prescription before paying any subscription. What the telehealth platforms are really selling on top of that commodity is access and convenience: a menopause-trained prescriber without a referral, an async intake instead of an appointment, auto-refills. That's worth something — just know it's what you're paying for.

Med-price-only telehealth: ~$63–128/month all-in

Two providers charge no recurring platform fee — the medication price is (almost) the whole price:

For a cash payer who wants one predictable bundled price, this model is the simplest — and Alloy's FDA-approved combo at ~$63/month is the lowest published all-in price in our comparison.

Membership models: what the fee actually buys

Teaser-price and pellet warnings

The whole market in one table

PathRealistic monthly costFDA-approved meds?Best for
Insurance: Midi visit + covered genericCopay-levelYesAnyone with a major PPO plan — check first
Your own doctor + pharmacy generic (cash + discount card)Varies — often lowest cashYesAnyone with a prescriber; price your Rx before subscribing
Evernow membership + your pharmacy$35–49 + medYesvia your pharmacyInsured Rx + menopause-trained clinician access
Alloy (med-price-only)~$63–123YesCheapest bundled all-in price, FDA-approved forms
Winona (med-price-only, compounded)~$89–128No — compoundedCream-format preference, accepting the trade-offs
Joi (membership + labs + meds)~$100–150+Mixed — some compoundedLabs-first monitoring model, 3-month commitment OK
Midi self-pay (no insurance)$250 initial / $150 follow-ups + medYesvia your pharmacyVisit-based specialist care without a subscription

HRT prices and promos move. We track them so you don't have to.

Get one short email when a price drops or terms change. No spam, no health questions.

We only ever ask for your email. See our privacy policy.

Sources (verified Aug 27, 2026): myalloy.com/solutions and myalloy.com/terms-of-use; bywinona.com/product and bywinona.com/faq; evernow.com/faq; joinmidi.com/pricing-insurance; joiandblokes.com/product/hrt; forhers.com menopause pages restrict automated access — figures withheld pending hand-verification; FTC v. Hims & Hers (July 2026, public filings). Treatment decisions belong with a licensed clinician — see our medical disclaimer.